Skip to main navigation Skip to search Skip to main content

The Impact of Clinical Pharmacist Diabetes Education on Medication Adherence in Patients with Type 2 Diabetes Mellitus: An Interventional Study from Khartoum, Sudan

  • Safaa Badi
  • , Sara Zainelabdein Suliman
  • , Rayan Almahdi
  • , Mohammed A. Aldomah
  • , Mohamed ELsir Marzouq
  • , Eiman Eltayeb M. Ibrahim
  • , Musaab Ahmed
  • , Mohamed H. Ahmed
  • , Habab Khalid Elkheir
  • , Mohamed Izham Mohamed Ibrahim
  • Omdurman Islamic University
  • Milton Keynes University Hospital NHS Foundation Trust
  • Sudan University of Science and Technology
  • Qatar University

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Background: Continuous therapeutic care with good medication adherence is the cornerstone of management of all chronic diseases including diabetes. This study aimed to evaluate the impact of clinical pharmacist intervention on the medication adherence in individuals with type 2 diabetes (T2DM). Methods: This was a randomized, double-blind, controlled trial conducted at a diabetes clinic located at Omdurman Military Hospital, Sudan. Individuals with T2DM attending the diabetes clinic within 1 year were selected. The sample size was 364 participants (182 control and 182 interventional group). We used a pre-structured standardized questionnaire and checklist to collect the data. Data were analyzed by using the Statistical Package for the Social Sciences (SPSS) (version 28). Results: Majority, 76.4% (n = 278) were females, and they consisted of 80.8% (n = 147) of the interventional group and 72% of the controls. The mean age of the interventional group was 54.5 (±10) years; 31.9% (n = 58) of the interventional group had diabetes for 6–10 years, compared with 26.4% (n = 48) of the control group. Among the control group, the mean adherence score was 6.8 (±1.7) at baseline and it was 6.7 (±1.6) at the end of the study (p < 0.001), while in the interventional group, the mean adherence score was 6.8 (±1.7) at baseline and it was 7.4 (±1.5) at the end of the study (p < 0.001). Conclusion: Adherence score among the intervention group was increased significantly from baseline to the end of the study when compared to the control group.

Original languageEnglish
Article number74
JournalJournal of Personalized Medicine
Volume14
Issue number1
DOIs
StatePublished - Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • adherence
  • clinical pharmacists
  • diabetes
  • medications

Fingerprint

Dive into the research topics of 'The Impact of Clinical Pharmacist Diabetes Education on Medication Adherence in Patients with Type 2 Diabetes Mellitus: An Interventional Study from Khartoum, Sudan'. Together they form a unique fingerprint.

Cite this